Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia reports developments tied to its patient activation platform for healthcare providers, life sciences companies and other organizations. The company’s recurring news includes quarterly results, stakeholder letters, patient intake, outreach, education and appointment-scheduling solutions, and the scale of patient visits enabled through its digital workflows.
Company updates also cover healthcare payment capabilities, including the completed AccessOne acquisition, credit-facility refinancing, and corporate governance or workplace recognition items. Phreesia’s news flow is centered on software, payments and engagement tools used across healthcare delivery and patient interactions.
Phreesia, Inc. (NYSE:PHR) has priced its public offering of 5,000,000 shares of common stock at $32.00 per share, with a potential net proceeds of approximately $151.6 million, or $174.4 million if underwriters exercise their option for 750,000 additional shares. The offering is expected to close on October 23, 2020, subject to customary conditions. J.P. Morgan and William Blair serve as joint book-running managers. The offering's details are available via a prospectus supplement filed with the SEC.
Phreesia, Inc. (NYSE: PHR) has launched an underwritten public offering of 5,000,000 shares of its common stock, with an option for underwriters to acquire an additional 750,000 shares. The offering is subject to market conditions, and its completion is not guaranteed. J.P. Morgan and William Blair serve as joint book-running managers. The offering is registered under an automatic shelf registration statement with the SEC, and further details will be provided in a prospectus supplement. Phreesia provides a comprehensive patient intake management platform for healthcare organizations.
Phreesia has acquired two innovative web-based workflow applications co-developed by Geisinger and Merck, aimed at enhancing patient care and communication. The Family Caregiver application promotes coordination for oncology patients, while MedTrue™ assists in medication reconciliation. These applications will be integrated into Phreesia's existing electronic health record systems, supporting the company's mission to improve healthcare efficiency and patient engagement. This acquisition builds on a fruitful collaboration between the involved parties.